BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, June 15, 2026
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for March 12, 2024

March 12, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbott, Edwards, Heartflow, Heartsciences, Medtronic, Merakris.
Read More

In the clinic for March 12, 2024

March 12, 2024
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications:Akeso, Cynata, Immutep.
Read More

In the clinic for March 11, 2024

March 11, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acumen, Akero, Amylyx, Arrowhead, Athira, Curasen, Inventiva, Kiora, Promontory, Regeneron, Spisparc, Vaxxinity.
Read More

In the clinic for March 11, 2024

March 11, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Clarity Pharmaceuticals.
Read More

In the clinic for March 8, 2024

March 8, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alligator, Alphyn, Arch, Gabather, Gilead, GSK, Immuron, Nodthera, Persica, Salix, Ultimovacs, Upstream, Viiv.
Read More

In the clinic for March 8, 2024

March 8, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Daxor, Insulet, Senseonics.
Read More

In the clinic for March 7, 2024

March 7, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akeso, Biogen, Biomea, Gilead, Grace, Innate, Kura, Laminar, Maia, Nektar, Oncusp, Telios.
Read More

In the clinic for Mar. 7, 2024

March 7, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbott, AI Medical Technology, Neuroelectrics, Sensible Medical.
Read More

In the clinic for March 6, 2024

March 6, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alnylam, Alzecure, Ankyra, Apogee, Bioinvent, Cervomed, Constant, Cynata, Elysium, Exonate, FSD, Immunitybio, Immutep, Inmune, Maat, Modex, Nielsen, Novo Nordisk, Regenxbio, Viiv, Vir.
Read More

In the clinic for Mar. 6, 2024

March 6, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bodyport, Endotronix, Know Labs, Koya Medical, Nexalin Technology.
Read More
Previous 1 2 … 100 101 102 103 104 105 106 107 108 … 326 327 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • Purple molecules

    Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

    BioWorld
    Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
  • 3D illustration of a nerve cell

    Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?

    BioWorld
    Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
  • Illustration of Lactobacillus

    Microbiota modulates the antidepressant effects of GLP-1 analogues

    BioWorld Science
    Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing